Kriya Therapeutics presented preclinical data on its gene therapy candidate for the treatment of geographic atrophy.

Sylentis recently announced topline results from the SYL1801_II phase 2a study investigating SYL1801 for the treatment of ...

Ophthalmologist Tarek Hassan introduces new surgical approach for proliferative vitreoretinopathy, using precise small retinotomies instead of extensive retinal removal to improve patient outcomes.

Biotechnology company Lineage Cell Therapeutics recently announced it will be presenting data from its phase 1/2a clinical study (NCT02286089) at the upcoming Clinical Trials at the Summit (CTS) 2025 ...

Ashvattha Therapeutics recently announced positive interim phase 2 results for migaldendranib (MGB). 1 MGB is described as a novel subcutaneously administered nanomedicine for the treatment of retinal ...

Four-year study shows faricimab in treat-and-extend regimen maintains vision for diabetic macular edema patients with significantly fewer injections over time. Matt Star, MD, assistant professor of ...

Ultra-wide field imaging shows nonperfusion and leakage independently predict diabetic retinopathy progression, suggesting earlier treatment with anti-VEGF or photocoagulation may prevent ...

Post hoc analysis of GATHER1 and GATHER2 showed that reduced EZ-RPE central subfield thickness is a strong predictor of greater future vision loss. A post hoc analysis of the GATHER1 and GATHER2 ...

Palatin Technologies recently announced preclinical data on the company’s melanocortin agonists PL9654 and PL9655. Both agents were found to have efficacy across multiple models and routes of ...

Duke professor Sharon Fekrat, MD, discusses AI-driven ophthalmology with smartphone diagnostics and robotic procedures, emphasizing global collaboration and innovative medical research. Sharon Fekrat, ...